Sobhan Oncology Pharmaceutical Company exported more than 30,000 packages of anti-cancer drug “Gemcitabine” to Iraq, as part of a contractual agreement with an Iraqi pharmaceutical company. The export permits for these shipments were issued by the Islamic Republic of Iran customs administration in late April of this year.

The CEO of Sobhan Oncology Pharmaceutical Company recently announced in an interview the company’s plans to expand its export of pharmaceutical products to other countries. According to his statements, the company’s efforts are focused on surpassing the $3 million mark in export volume for the current year.